SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

Skin & hair

What Basal Cell Carcinoma Looks Like: A Plain-Language Guide

Basal cell carcinoma most often looks like a pearly or shiny bump, a pink or red growth, or a flat scar-like patch on sun-exposed skin. It may bleed easily or repeatedly heal and reopen. Any spot matching these signs that persists or changes for more than four to six weeks warrants a clinician's evaluation.

Talk to a clinician

Nina Osei, NP — Nurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

What does BCC actually look like?

There is no single appearance for basal cell carcinoma — it has several subtypes, each with a distinct look.

Nodular BCC (the most common subtype) presents as a small, shiny or pearly pinkish bump, often translucent or flesh-colored, sometimes with tiny red blood vessels (telangiectasias) visible across its surface. Over time it may develop a central sore that bleeds, scabs, and appears to heal — only to reopen. This heal-and-reopen cycle is one of the most characteristic and important patterns to recognize 1.

Superficial BCC looks flat or slightly raised — a pink-red patch with a faintly scaly or crusted surface, most often on the trunk or shoulders. It is easily mistaken for dry skin, eczema, or psoriasis.

Morpheaform (sclerosing) BCC resembles a pale, slightly waxy scar with no history of injury. Its edges blend into surrounding skin, making it harder to notice and often leading to delayed diagnosis.

All three subtypes favor chronically sun-exposed areas: the face (nose, inner eye corner, lip, ear), scalp, neck, and upper chest 1. BCC almost never appears on skin that has been chronically covered.

What is BCC and why does it form?

Basal cell carcinoma arises from the basal cells — the deepest layer of the outer skin (epidermis). Cumulative UV radiation from the sun or tanning beds causes DNA damage in these cells over years and decades, driving abnormal growth via mutations in the hedgehog signaling pathway 2. BCC is the most common malignant tumor in people with lighter skin, with an estimated lifetime risk of approximately 30% in this population 2.

BCC grows slowly and rarely spreads to other organs, which distinguishes it from melanoma. Left untreated for years, however, it can grow deeply into nearby tissues — particularly around the eye, ear, and nose where vital structures lie close. The reassuring fact: when found and treated early, cure rates are excellent, with 5-year cure rates above 95% for primary lesions 1.

Who is at higher risk of developing BCC?

BCC is most common in fair-skinned individuals with a history of cumulative sun exposure — particularly those who had blistering sunburns in childhood, worked outdoors for many years, or used tanning beds 3. Risk rises steadily with age, though BCC can occur in younger adults, and the incidence has been increasing for decades worldwide 2.

A personal history of any prior skin cancer substantially raises the likelihood of another. Organ transplant recipients and people on long-term immunosuppressive medications face significantly higher risk and may develop more aggressive lesions 1. Regular skin checks are particularly important in these groups.

Why does early detection matter so much?

The smaller a BCC is when treated, the simpler the procedure, the smaller the resulting scar, and the lower the risk of recurrence. Most BCCs are treated with a shave excision, standard surgical excision, or Mohs micrographic surgery for higher-risk locations on the face and ears. Mohs surgery achieves 5-year cure rates of 99% for primary BCC by removing tissue one layer at a time and checking margins in real time 4.

There is no blood test for BCC. Detection depends entirely on a trained eye examining the skin. This is why annual full-body skin checks are recommended for anyone in a higher-risk group 1. Delaying evaluation of a suspicious lesion allows a BCC to grow into deeper tissue, requiring more extensive surgery and increasing the risk of local recurrence.

What should you do if you spot something suspicious?

No article or photo comparison can diagnose BCC — only a clinician examining your skin can do that. If you have a spot that concerns you:

  • Take a clear, close-up photo in natural light today to document the current appearance.
  • Note how long it has been there and whether it has changed in size, color, or behavior.
  • Schedule a visit with a dermatologist or your primary care clinician.

If the clinician is concerned, a small skin biopsy — removing a tiny tissue sample under local anesthesia — provides a definitive answer from a dermatopathologist. A biopsy is a minor, routine procedure. Waiting is the greater risk.

How do clinicians confirm the diagnosis?

Dermoscopy — a hand-held polarized-light device — allows a dermatologist to see vascular patterns and structural features within the lesion that are invisible to the naked eye. BCC has characteristic dermoscopic patterns (arborizing vessels, blue-gray ovoids, leaf-like areas) that help distinguish it from benign lesions 1.

Skin biopsy (shave or punch) sends a small tissue sample to a dermatopathologist. This is the definitive test. No imaging or blood test substitutes for biopsy in confirming a BCC diagnosis and identifying its subtype, which matters for treatment planning 4.

Common questions

Can BCC appear somewhere other than sun-exposed skin?

It is uncommon but possible. BCC very rarely develops on covered skin — the overwhelming majority occur on chronically sun-exposed sites. If a suspicious lesion appears on covered skin, a clinician can still evaluate it, but the prior probability of BCC is lower.

Is BCC the same as melanoma?

No. BCC and melanoma are different cancers. Melanoma arises from pigment-producing cells, spreads to other organs more readily, and carries a higher mortality risk. BCC is far more common and almost always stays local. Both require prompt evaluation, but they are treated differently.

How do I know if a spot is BCC or just a pimple or cyst?

Pimples typically resolve within days to a few weeks. A BCC will not resolve — it may appear to heal briefly but then reopen. A pearly or translucent bump that persists for more than four to six weeks, especially on the face or ears, warrants a clinician's evaluation rather than watchful waiting at home.

Do I need a dermatologist, or can my primary care doctor evaluate a suspicious spot?

A primary care clinician can perform an initial evaluation and refer when needed. For a suspicious lesion on the face, scalp, or ear, or if you have a history of prior skin cancer, a dermatologist is the appropriate first stop — dermoscopy and biopsy are routine parts of a dermatology visit.

Does sunscreen help prevent BCC?

Broad-spectrum sunscreen with adequate SPF, used consistently, reduces cumulative UV exposure and is a meaningful part of skin cancer prevention. It does not eliminate risk entirely, but the evidence supports regular use as part of a photoprotection strategy.

Talk to a clinician

Nina Osei, NP — Nurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

When to see a clinician

  • —Any skin growth that bleeds easily or repeatedly without injury
  • —A sore on the face, head, neck, or ears that heals and reopens in a cycle
  • —A shiny, translucent, or pearly bump that has been present for more than four to six weeks
  • —A flat, pale, or scar-like lesion with no injury history
  • —Any new or changing spot if you have a history of prior skin cancer

This article is general health education about basal cell carcinoma and is not a personalized diagnosis. Only a licensed dermatologist or clinician who examines your skin can evaluate a specific lesion. If you have a concerning spot, schedule an appointment rather than relying on any description or image comparison.

References

  1. 1.American Academy of Dermatology (2024). Skin cancer types: Basal cell carcinoma diagnosis and treatment. AAD Public Resource. link ✓BCC subtypes and their clinical appearances; characteristic heal-and-reopen cycle; high-risk locations on face and ears; immunosuppression as a risk factor; skin biopsy as the definitive diagnostic step; dermoscopic features of BCC
  2. 2.Seidl-Philipp M, Frischhut N, Höllweger N, Schmuth M, Nguyen VA (2021). Known and new facts on basal cell carcinoma. Journal der Deutschen Dermatologischen Gesellschaft. doi:10.1111/ddg.14580 ✓BCC as the most common malignant tumor in light-skinned individuals; lifetime risk ~30%; hedgehog pathway mutations as the central pathogenic mechanism; rising incidence worldwide; key risk factors including UV exposure, age, and skin type
  3. 3.Teng Y, Yu Y, Li S, Huang Y, Xu D, Tao X, Fan Y (2021). Ultraviolet Radiation and Basal Cell Carcinoma: An Environmental Perspective. Frontiers in Public Health. doi:10.3389/fpubh.2021.666528 ✓UV radiation as the primary environmental cause of BCC; childhood sunburns and outdoor occupational exposure as risk factors; tanning bed use increasing BCC risk; cumulative UV dose relationship with BCC risk
  4. 4.National Center for Biotechnology Information (2023). Mohs Micrographic Surgery. StatPearls — NCBI Bookshelf. link ✓Mohs micrographic surgery achieving 5-year cure rates of 99% for primary BCC and 94.4% for recurrent BCC; real-time intraoperative margin assessment; tissue-sparing approach for high-risk facial locations; biopsy subtype identification as prerequisite for treatment planning

4 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.